Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWTimosaponin BII (TB-II) is a steroidal saponin that has been found in Anemarrhenae and has diverse biological activities.1,2,3 TB-II (20-100 µM) inhibits superoxide generation induced by phorbol 12-myristate 13-acetate (PMA; Item No. 10008014), N-formyl-Met-Leu-Phe (fMLP; Item No. 21495), or arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607) in isolated human neutrophils.1 It reduces cell death induced by enterovirus 71 (EV71) in Vero cells (IC50 = 4.3 µM).2 TB-II (20, 40, and 80 mg/ml) inhibits ADP-induced platelet aggregation in isolated rabbit platelet-rich plasma (PRP).3 TB-II (3 and 6 mg/kg) increases activated partial thromboplastin time (APTT) and decreases the wet weight and length of thrombi in Chandler’s ex vivo thrombosis model.
WARNING This product is not for human or veterinary use.
1. Effect of steroidal saponins of Anemarrhenae rhizoma on superoxide generation in human neutrophils. Biochem. Biophys. Res. Commun. 259(3), 636-639 (1999).
2. Folding fan mode counter-
3. Antiplatelet and antithrombotic activities of timosaponin B‐II, an extract of Anemarrhena asphodeloides. Clin. Exp. Pharmacol. Physiol. 38(7), 430-434 (2011).